Human herpesvirus-8: What (not) to do?

Transfusion

Volumn 45, Issue 4, 2005, Pages 463-465

  Dodd, Roger Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BLOOD DONOR; BLOOD TRANSFUSION; CYTOMEGALOVIRUS; EDITORIAL; EPSTEIN BARR VIRUS; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNE DEFICIENCY; INFECTION RISK; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHUMAN; ORGAN TRANSPLANTATION; RECIPIENT; RECURRENT DISEASE; SAFETY; SALIVA; SEXUAL TRANSMISSION; VARICELLA ZOSTER VIRUS; VIRUS TRANSMISSION;

BLOOD DONORS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS;

EID: 17044414073     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2005.05008.x     Document Type: Editorial

References (16)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
2. Dourmishev LA, Dourmishev AL, Palmeri D, et al. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 2003;67:175-212.
3. Cattani P, Capuano M, Graffeo R, et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol 2001;39:506-8.
4. Farge D, Lebbé C, Marjanovic Z, et al. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Transplantation 1999;67:1236-42.
5. Regamey N, Tamm M, Wernli M, et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998;339:1358-63.
6. Blackbourn DJ, Ambroziak J, Lennette E, et al. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997;349:609-11.
7. Operskalski EA, Busch MP, Mosley JW, et al. Blood donations and viruses. Lancet 1997;349:1327.
8. Engels EA, Eastman H, Ablashi DV, et al. Risk of transfusion-associated transmission of human herpesvirus 8. J Natl Cancer Inst 1999;91:1773-5.
9. Cannon MJ, Dollard SC, Smith DK, et al. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 2001;344:637-43.
10. Challine D, Roudot-Thoraval F, Sarah T, et al. Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses. Transfusion 2001;41:1120-5.
11. Mbulaiteye SM, Biggar RJ, Bakaki PM, et al. Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst 2003;95:1330-5.
12. Pellett PE, Wright DJ, Engels EA, et al. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003;43:1260-8.
13. Corchero JL, Mar EC, Spira TJ, et al. Comparison of serologic assays for detection of antibodies against human herpesvirus 8. Clin Diagn Lab Immunol 2001;8:913-21.
14. Dollard SC, Nelson KE, Ness PM, et al. Possible transmission of human herpesvisrus-8 by blood transfusion in a historical United States Cohort. Transfusion 2005;45:500-3.
15. Issue summary. Topic II. The potential risk of simian foamy virus transmission by blood transfusion [Internet]. Gaithersburg (MD): Blood Products Advisory Committee; 2004. Available from: http://www.fda.gov/ohrms/dockets/ac/ 04/briefing/2004-4074b1_02_topic%202.htm
16. Foster KR, Vecchia P, Repacholi MH. Risk management: science and the precautionary principle. Science 2000;288:979-81.